These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3148481)

  • 21. Prevention and management of RhD isoimmunization.
    Harkness UF; Spinnato JA
    Clin Perinatol; 2004 Dec; 31(4):721-42, vi. PubMed ID: 15519425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Response to the comment by N. Lahmann on "Current problems of blood group incompatibility in pregnancy"].
    Wilken H
    Zentralbl Gynakol; 1989; 111(6):388-9. PubMed ID: 2499138
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemolytic disease of the newborn due to anti-c.
    Saenz RB
    J Tenn Med Assoc; 1993 Jan; 86(1):9-11. PubMed ID: 8455385
    [No Abstract]   [Full Text] [Related]  

  • 24. Perinatal management of fetal hemolytic disease due to Rh incompatibility combined with fetal alloimmune thrombocytopenia due to HPA-5b incompatibility.
    Schild RL; Hoch J; Plath H; Geissen C; Fahnenstich H; Dame C; Hansmann M
    Ultrasound Obstet Gynecol; 1999 Jul; 14(1):64-7. PubMed ID: 10461341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
    Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
    [No Abstract]   [Full Text] [Related]  

  • 26. [Novel treatments of Rh-immunization].
    Ulander VM; Halmesmäki E; Ammälä P
    Duodecim; 2004; 120(24):2897-904. PubMed ID: 15700584
    [No Abstract]   [Full Text] [Related]  

  • 27. Do we need to be more concerned about weak D antigens?
    Garratty G
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comment on H. Wilken: Current problems of blood group incompatibility in pregnancy, Zent.bl. Gynäkol. 110 (1988) 1-11].
    Lahmann N
    Zentralbl Gynakol; 1989; 111(6):385-7. PubMed ID: 2499137
    [No Abstract]   [Full Text] [Related]  

  • 29. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 30. [Infection risk factors in newborn infants with fetal erythroblastosis].
    Maszkiewicz W; Ornat K; Laskowska B; Irzyńska D; Manerowska D
    Acta Haematol Pol; 1988; 19(3-4):230-8. PubMed ID: 3150899
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy and prevention of hemolytic disease of the newborn caused by the Rh factor].
    Kogoj-Bakic V
    Lijec Vjesn; 1970 Nov; 92(11):1323-31. PubMed ID: 4332439
    [No Abstract]   [Full Text] [Related]  

  • 32. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction].
    Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C
    Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rh-immunoglobulin: Rh prophylaxis.
    Bowman J
    Best Pract Res Clin Haematol; 2006; 19(1):27-34. PubMed ID: 16377539
    [No Abstract]   [Full Text] [Related]  

  • 34. [Successively improved prognosis in erythrocyte immunization].
    Westgren M; Bui TH; Grunewald C; Kublickas M; Kalsson A; Wolff K; Shanwell A
    Lakartidningen; 1998 May; 95(22):2594-9. PubMed ID: 9640939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pregnancy and immunization].
    Tamsen L; Lindberg B
    Jordemodern; 1990; 103(1-2):14-20. PubMed ID: 2108941
    [No Abstract]   [Full Text] [Related]  

  • 36. [Perinatal hemolytic disease caused by anti-c. A clinical case].
    Donoso Siña E; Herrera Gonzalez B; González Bruzzone P; Cuellar Castañón A
    Rev Chil Obstet Ginecol; 1983; 48(3):175-9. PubMed ID: 6442780
    [No Abstract]   [Full Text] [Related]  

  • 37. Apparent relationship between vacuolization of fetal erythrocytes and anemia in red cell alloimmunization.
    Egberts J; van den Bosch N; Kanhai HH; Mouw RJ; van Kamp IL; Beintema-Dubbeldam A; Bennebroek Gravenhorst J
    Vox Sang; 1995; 69(1):87-8. PubMed ID: 7483507
    [No Abstract]   [Full Text] [Related]  

  • 38. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of fetomaternal alloimmunization].
    Mannessier L
    Transfus Clin Biol; 2000 Dec; 7(6):525-6. PubMed ID: 11204836
    [No Abstract]   [Full Text] [Related]  

  • 40. Rh isoimmunization related to amniocentesis.
    Murray JC; Karp LE; Williamson RA; Cheng EY; Luthy DA
    Am J Med Genet; 1983 Dec; 16(4):527-34. PubMed ID: 6419606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.